Prognostic value of pathological tumor size in patients with supraglottic carcinoma.


Journal

American journal of otolaryngology
ISSN: 1532-818X
Titre abrégé: Am J Otolaryngol
Pays: United States
ID NLM: 8000029

Informations de publication

Date de publication:
Historique:
received: 05 08 2020
revised: 14 09 2020
accepted: 11 10 2020
pubmed: 1 11 2020
medline: 28 4 2021
entrez: 31 10 2020
Statut: ppublish

Résumé

The association between pathological tumor size and predictive value in patients with supraglottic carcinoma who receive surgery is poorly understood. To gain further insight into this association, the influence of postoperative tumor size assessed via pathological evaluation on survival outcomes in patients with supraglottic carcinoma was fully analyzed. This study collected data from 375 consecutive supraglottic carcinoma patients who underwent primary surgical treatment between 2005 and 2010. The parameters of tumor size, including tumor diameter, tumor area, and tumor volume, were used to analyze the prognostic abilities of overall survival (OS) and disease-free survival (DFS) in supraglottic carcinoma. Twelve women and 363 men were included, with a mean age of 61.2 years. The 5-year OS and DFS rates were 65.4% and 56.2%, respectively. The mean tumor diameter, tumor area, and tumor volume of all patients was 3.1 cm, 8.6 cm Patients with a larger tumor size have inferior survival outcomes, and tumor area and tumor volume are independent predictive parameters of survival in supraglottic carcinoma patients who are treated with primary surgery.

Sections du résumé

BACKGROUND BACKGROUND
The association between pathological tumor size and predictive value in patients with supraglottic carcinoma who receive surgery is poorly understood. To gain further insight into this association, the influence of postoperative tumor size assessed via pathological evaluation on survival outcomes in patients with supraglottic carcinoma was fully analyzed.
MATERIALS AND METHODS METHODS
This study collected data from 375 consecutive supraglottic carcinoma patients who underwent primary surgical treatment between 2005 and 2010. The parameters of tumor size, including tumor diameter, tumor area, and tumor volume, were used to analyze the prognostic abilities of overall survival (OS) and disease-free survival (DFS) in supraglottic carcinoma.
RESULTS RESULTS
Twelve women and 363 men were included, with a mean age of 61.2 years. The 5-year OS and DFS rates were 65.4% and 56.2%, respectively. The mean tumor diameter, tumor area, and tumor volume of all patients was 3.1 cm, 8.6 cm
CONCLUSIONS CONCLUSIONS
Patients with a larger tumor size have inferior survival outcomes, and tumor area and tumor volume are independent predictive parameters of survival in supraglottic carcinoma patients who are treated with primary surgery.

Identifiants

pubmed: 33128995
pii: S0196-0709(20)30451-8
doi: 10.1016/j.amjoto.2020.102757
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102757

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Hongli Gong (H)

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Liang Zhou (L)

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China. Electronic address: zhoulent@126.com.

Chi-Yao Hsueh (CY)

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Haitao Wu (H)

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Lei Tao (L)

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Ming Zhang (M)

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Xiaoling Chen (X)

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Cai Li (C)

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Miao Mo (M)

Department of Clinical Statistics Center, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

Jian Zhou (J)

Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai 200031, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH